Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianxi Shi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
BMC Cancer|February 19, 2024
Transcriptomics analysis revealed that TAZ regulates the proliferation of KIRC cells through mitophagyZhen He, Jianxi Shi, Bing Zhu, et al.
Journal of Clinical Medicine|August 12, 2023
The Present and Future of Artificial Intelligence in Urological CancerXun Liu, Jianxi Shi, Zhaopeng Li, et al.
Frontiers in Oncology|September 8, 2025
Ginsenoside Rh2 repressed the progression of prostate cancer through the mitochondrial damage induced by mitophagy and ferroptosisZhen He, Jianxi Shi, Bing Zhu, et al.
Ecotoxicology and Environmental Safety|June 24, 2021
Antimony exposure promotes bladder tumor cell growth by inhibiting PINK1-Parkin-mediated mitophagyYantao Lou, Chunlei Ma, Zhifei Liu, et al.
Ecotoxicology and Environmental Safety|May 6, 2025
The PPARβ/CERK/C1P signaling pathway is a potential mechanism by which antimony exposure promotes prostate cancer cell proliferationJianxi Shi, Zhaopeng Li, Xiaoyu Sun, et al.
Chemosphere|August 10, 2023
Low-dose antimony exposure promotes prostate cancer proliferation by inhibiting ferroptosis via activation of the Nrf2-SLC7A11-GPX4 pathwayJianxi Shi, Chunlei Ma, Zhiwen Zheng, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
BMC Cancer|February 19, 2024
Transcriptomics analysis revealed that TAZ regulates the proliferation of KIRC cells through mitophagyZhen He, Jianxi Shi, Bing Zhu, et al.
Journal of Clinical Medicine|August 12, 2023
The Present and Future of Artificial Intelligence in Urological CancerXun Liu, Jianxi Shi, Zhaopeng Li, et al.
Frontiers in Oncology|September 8, 2025
Ginsenoside Rh2 repressed the progression of prostate cancer through the mitochondrial damage induced by mitophagy and ferroptosisZhen He, Jianxi Shi, Bing Zhu, et al.
Ecotoxicology and Environmental Safety|June 24, 2021
Antimony exposure promotes bladder tumor cell growth by inhibiting PINK1-Parkin-mediated mitophagyYantao Lou, Chunlei Ma, Zhifei Liu, et al.
Ecotoxicology and Environmental Safety|May 6, 2025
The PPARβ/CERK/C1P signaling pathway is a potential mechanism by which antimony exposure promotes prostate cancer cell proliferationJianxi Shi, Zhaopeng Li, Xiaoyu Sun, et al.
Chemosphere|August 10, 2023
Low-dose antimony exposure promotes prostate cancer proliferation by inhibiting ferroptosis via activation of the Nrf2-SLC7A11-GPX4 pathwayJianxi Shi, Chunlei Ma, Zhiwen Zheng, et al.
Pageof 1